Stryker Corporation $SYK Holdings Boosted by Capital Advisors Inc. OK

Capital Advisors Inc. OK raised its position in shares of Stryker Corporation (NYSE:SYK) by 14.4% during the 2nd quarter, Holdings Channel.com reports. The firm owned 205,253 shares of the medical technology company’s stock after acquiring an additional 25,767 shares during the period. Capital Advisors Inc. OK’s holdings in Stryker were worth $64,622,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. State Street Corp grew its holdings in shares of Stryker by 2.1% during the fourth quarter. State Street Corp now owns 15,254,407 shares of the medical technology company’s stock valued at $5,374,731,000 after buying an additional 311,507 shares in the last quarter. Wellington Management Group LLP lifted its stake in Stryker by 0.6% in the 2nd quarter. Wellington Management Group LLP now owns 8,167,185 shares of the medical technology company’s stock worth $2,571,357,000 after acquiring an additional 45,478 shares in the last quarter. Geode Capital Management LLC boosted its position in Stryker by 0.9% during the 4th quarter. Geode Capital Management LLC now owns 7,535,572 shares of the medical technology company’s stock worth $2,636,238,000 after acquiring an additional 69,851 shares during the period. Norges Bank purchased a new position in Stryker during the 4th quarter valued at about $1,822,272,000. Finally, Bank of America Corp DE purchased a new position in Stryker during the 2nd quarter valued at about $1,404,284,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insider Transactions at Stryker

In other news, insider Dylan Bram Crotty sold 441 shares of the stock in a transaction on Friday, August 21st. The shares were sold at an average price of $328.61, for a total transaction of $144,917.01. Following the transaction, the insider owned 6,102 shares in the company, valued at $2,005,178.22. This represents a 6.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Ronda E. Stryker sold 300,000 shares of the firm’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total transaction of $100,770,000.00. Following the transaction, the director owned 2,301,375 shares in the company, valued at $773,031,862.50. This represents a 11.53% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 351,267 shares of company stock worth $118,197,701 in the last 90 days. 4.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on SYK. Weiss Ratings reissued a “hold (c)” rating on shares of Stryker in a research report on Friday, July 31st. Truist Financial boosted their price objective on shares of Stryker from $330.00 to $340.00 and gave the company a “hold” rating in a research report on Friday, July 31st. Citigroup reiterated a “buy” rating on shares of Stryker in a research report on Thursday, August 13th. BTIG Research decreased their target price on shares of Stryker from $371.00 to $358.00 and set a “buy” rating for the company in a research note on Friday, July 31st. Finally, Evercore set a $350.00 price target on shares of Stryker in a report on Monday, July 6th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $386.28.

Stryker Stock Up 2.9%

Shares of Stryker stock opened at $331.32 on Friday. The firm has a market cap of $127.08 billion, a price-to-earnings ratio of 34.33, a P/E/G ratio of 2.11 and a beta of 0.76. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $396.86. The stock has a 50-day simple moving average of $329.10 and a 200-day simple moving average of $331.47.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping analysts’ consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The firm had revenue of $6.59 billion for the quarter, compared to the consensus estimate of $6.58 billion. During the same quarter in the prior year, the company posted $3.13 earnings per share. The firm’s revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, equities research analysts expect that Stryker Corporation will post 15.02 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s payout ratio is currently 36.48%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.